Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2018-07-30 Transaction in Own Shar…
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
REPURCHASED SHARES IN KARO PHARMA DURING WEEK 30 2018
Transaction in Own Shares Classification · 99% confidence The document explicitly details the repurchase of 'own shares' by Karo Pharma AB during a specific week (Week 30, 2018). It provides aggregated daily volume, weighted average price, and total transaction value for the repurchases, referencing the ongoing share repurchase program and compliance with MAR regulations. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2018-07-30 English
ÅTERKÖP AV AKTIER I KARO PHARMA UNDER VECKA 29 2018
Transaction in Own Shares Classification · 99% confidence The document title is "ÅTERKÖP AV AKTIER I KARO PHARMA UNDER VECKA 29 2018" (Repurchase of Shares in Karo Pharma during Week 29 2018). The text details the number of own shares repurchased during a specific period (July 16 - July 20, 2018) and references the ongoing share repurchase program. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is Transaction in Own Shares (POS).
2018-07-23 Swedish
REPURCHASED SHARES IN KARO PHARMA DURING WEEK 29 2018
Transaction in Own Shares Classification · 99% confidence The document explicitly details the repurchase of 'own shares' by Karo Pharma during a specific week (Week 29, 2018) and provides a breakdown of daily transactions, weighted average prices, and total value. This activity directly corresponds to the definition of a company buying back or selling its own shares. The filing category 'Transaction in Own Shares' (POS) is the most appropriate fit. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K).
2018-07-23 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Karo Pharma covering the period January to June 2018. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, management commentary, and board declarations. It is not an announcement of a report, but the report itself, containing substantive financial data. H1 2018
2018-07-19 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY – JUNE 2018' and contains comprehensive financial statements, including income statements, cash flow analysis, and management commentary for the specified period. It provides detailed financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim/Quarterly Report (IR). H2 2018
2018-07-19 English
ÅTERKÖP AV AKTIER I KARO PHARMA UNDER VECKA 28 2018
Transaction in Own Shares Classification · 99% confidence The document title is "ÅTERKÖP AV AKTIER I KARO PHARMA UNDER VECKA 28 2018" (Repurchase of Shares in Karo Pharma during Week 28 2018). The text details the number of own shares repurchased during a specific weekly period (July 9 - July 13, 2018) under an existing buyback program, referencing MAR regulations. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate classification is Transaction in Own Shares (POS).
2018-07-16 Swedish

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.